• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 前のページに戻る

Exploring a novel molecular pathway that underlies cerebellar contribution to autism spectrum disorder

研究課題

研究課題/領域番号 23K14826
研究種目

若手研究

配分区分基金
審査区分 小区分52030:精神神経科学関連
研究機関東海大学

研究代表者

モハメド ダルウィシュ  東海大学, 医学部, 奨励研究員 (60938934)

研究期間 (年度) 2023-04-01 – 2025-03-31
研究課題ステータス 交付 (2023年度)
配分額 *注記
4,420千円 (直接経費: 3,400千円、間接経費: 1,020千円)
2024年度: 1,950千円 (直接経費: 1,500千円、間接経費: 450千円)
2023年度: 2,470千円 (直接経費: 1,900千円、間接経費: 570千円)
キーワードNeurotropic factors / cerebellum development / ASD / Cerebellum
研究開始時の研究の概要

The cerebellum has been involved in neurodevelopmental disorders such as autism spectrum disorders (ASD). However, the molecular mechanism underlying cerebellar development/function and its implication in ASD are not fully understood. We identified a novel neurotropic factor as a potential key molecule for cerebellar development and ASD. I will use mouse genetics, together with molecular, electrophysiological, and behavioral approaches to uncover a novel molecular pathway that underlies cerebellar development and its involvement in ASD pathophysiology.

研究実績の概要

In the first fiscal year, I aimed to elucidate the receptor and signaling pathway of NDNF that work together to maintain proper brain development. To identify NDNF receptors and other binding partners, I performed co-immunoprecipitation-coupled mass spectrometry from HA-tagged NDNF mice brain and identified potential receptor and downstream signaling pathway for NDNF. Indeed, I confirmed this pathway using westernblot analysis. In addition, we discovered that the NDNF undergoes processing and cleavge into a potentially more potent form. Using in vitro experiments, this cleaved form showed superior effect compared to full-length NDNF.

現在までの達成度 (区分)
現在までの達成度 (区分)

2: おおむね順調に進展している

理由

I think that the progress during the first year was going well becasue we identified a novel signaling patwhay through NDNF that underlie brain development and function. In addition, we identified a potential active form of NDNF which could have a great therapeutic potential for treating neurodevelopmental disorders.

今後の研究の推進方策

In the next year, I plan to investigate whether NDNF receptor is involved in cerebellum development and the pathophysiology of neurodevelopmental disorders, I will knockout the receptor in the cerebellum using virus-based in vivo genome editing and compare morphological and behavioral characteristics to those of Ndnf KO mice. Next, I will investigate whether activating NDNF signaling pathway restores cerebellum function in Ndnf KO mice to confirm causality between NDNF signaling pathways and brain development.
Besides, I aim to check the theraputic potential of NDNF in treating neurodevelopmental disorders. I will inject the cleaved and full length peptide into the cerebellum of neonatal Ndnf KO mice to investigate its therapeutic effect in preventing neurodevelopmental phenotypes.

報告書

(1件)
  • 2023 実施状況報告書
  • 研究成果

    (2件)

すべて 2023

すべて 学会発表 (2件)

  • [学会発表] Exploring a novel molecular pathway underlies cerebellar development and autism spectrum disorder2023

    • 著者名/発表者名
      Mohamed Darwish, Yoko Iijima, Takatoshi Iijima.
    • 学会等名
      The 64th Annual Meeting of the Japanese Society of Neuropathology /The 66th Annual Meeting of the Japanese Society of Neurochemistry.
    • 関連する報告書
      2023 実施状況報告書
  • [学会発表] Exploring a novel molecular pathway underlies cerebellar development and autism spectrum disorder2023

    • 著者名/発表者名
      Mohamed Darwish, Yoko Iijima, Takatoshi Iijima.
    • 学会等名
      The 44th Annual Meeting of the Japanese Neuroscience Society.
    • 関連する報告書
      2023 実施状況報告書

URL: 

公開日: 2023-04-13   更新日: 2024-12-25  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi